MyBlueDots

FT. MYERS, Fla.–(BUSINESS WIRE)–NeoGenomics’ Chris Smith will retire as CEO and board member, effective April 1, 2025. Tony Zook will assume the role of CEO at that time.

LONDON & NEW YORK–(BUSINESS WIRE)—- $CMPS #Biotech–Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricing of an underwritten offering of 24,014,728 American Depositary Shares (“ADSs”) and in lieu of ADS, to certain institutional investors, pre-funded warrants to purchase up to 11,044,720 ADSs. Each ADS and pre-funded warrant shall be accompanied by a warrant (“ADS Warrant”) to purchase one

DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the first quarter of fiscal 2025, which ended November 30, 2024. Chief Executive Officer Tim Wentworth said: “Our first quarter results reflect our disciplined execution against our 2025 priorities: stabilizing the retail pharmacy by optimizing our footprint, controlling operating costs, improving cash flow and continuing to address reimbursement models,” said Tim Wentworth, Chie

BILLERICA, Mass. and MARLBOROUGH, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, and Akoya Biosciences (NASDAQ: AKYA), The Spatial Biology Company®, today announced a definitive merger agreement under which Quanterix will acquire Akoya in an all-stock transaction. The transaction will create the first integrated solution for ultra-sensitive detection of blood- and tissue-based protein biomarkers.

CHICAGO–(BUSINESS WIRE)– #GvokeHypoPen–Xeris Biopharma Holdings, Inc. (Nasdaq: XERS) today announced it expects to generate total 2024 revenue of $203 million, which will exceed previously announced 2024 total revenue guidance of $198 million to $202 million. The Company also anticipates ending 2024 with over $71 million in cash, cash equivalents, and short-term investments, generating positive cash flow in the fourth quarter. “We achieved another record quarter of exceptional total revenue growth with reve

PALO ALTO, Calif.–(BUSINESS WIRE)–Ronald McDonald House Charities Bay Area (RMHC Bay Area) is thrilled to announce the appointment of six dynamic new members to its Board of Directors. Each brings a unique mix of experience, passion, and commitment to the organization’s mission and programs that remove barriers, strengthen families and promote healing. The new board members, joining RMHC Bay Area, include: Chase Lyman, co-chief real estate officer at the Sobrato Organization and a long-time s

NASHVILLE, Tenn.–(BUSINESS WIRE)– #biohacking–Next Health debuts in Tennessee with its first Nashville location opening Jan. 20 in The Gulch, offering health optimization and longevity services.

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced positive topline results from its pivotal Phase 3 CREST trial evaluating sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination with Bacillus Calmette-Guérin (BCG) as induction therapy with or without maintenance in patients with BCG-naïve, high-risk non-muscle invasive bladder cancer (NMIBC). The study met its primary endpoint of event-free survival (EFS) by investigator assessment, demonstrating a c

DUBLIN–(BUSINESS WIRE)–The “Medical PET Patent Landscape Report” has been added to ResearchAndMarkets.com’s offering. This report presents an in-depth analysis of the patent landscape for Medical PET, encompassing 1,408 patents filed from 2010 to 2024. The field of Medical PET has witnessed notable growth, with recent years showcasing a surge in innovation aligned with the expanding applications of PET in healthcare. The United States leads in patent registrations, followed by contributions f